NCT05319158 The Effect of the Movement Imitation Therapy in Preterm (MIT-PB) in Motor Behavior's Quality.
| NCT ID | NCT05319158 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta |
| Condition | Premature Birth |
| Study Type | INTERVENTIONAL |
| Enrollment | 36 participants |
| Start Date | 2022-04-04 |
| Primary Completion | 2026-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 36 participants in total. It began in 2022-04-04 with a primary completion date of 2026-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to assess the effect of a parent-administered intervention program based on MIT-PB in preterm with abnormal general movements during the preterm period. We will describe the short and long-term differences between infants exposed to MIT-PB and infants who follow current standard care.
Eligibility Criteria
Inclusion Criteria: * Preterm infants born before 32w GA and less than 1500g weight. * Infants who show Abnormal General Movements (CS-PR pattern) at 34-36w postmenstrual age (PMA). * Families able to understand/speak Catalan, Spanish or English. * Families willing to participate who have the informed consent Exclusion Criteria: * Infants with congenital abnormalities and/or genetic disorders * Infants with invasive ventilation or Continuous Positive Airway Pressure (CPAP) at 36 weeks PMA. * Infants with Normal General Movements at 34-36 w PMA. * Families not willing to participate.
Contact & Investigator
Susana Trallero, MsC
PRINCIPAL INVESTIGATOR
International University of Catalonia
Frequently Asked Questions
Who can join the NCT05319158 clinical trial?
This trial is open to participants of all sexes, aged 22 Weeks or older, up to 32 Weeks, studying Premature Birth. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05319158 currently recruiting?
Yes, NCT05319158 is actively recruiting participants. Contact the research team at sue.trallero@gmail.com for enrollment information.
Where is the NCT05319158 trial being conducted?
This trial is being conducted at Barcelona, Spain, Sabadell, Spain, Girona, Spain.
Who is sponsoring the NCT05319158 clinical trial?
NCT05319158 is sponsored by Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta. The principal investigator is Susana Trallero, MsC at International University of Catalonia. The trial plans to enroll 36 participants.